We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.37B
AUM Growth
-$13.6M
Cap. Flow
+$14.5M
Cap. Flow %
0.61%
Top 10 Hldgs %
39.42%
Holding
115
New
26
Increased
36
Reduced
14
Closed
20

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$60.1M
2
AMZN icon
Amazon
AMZN
+$54.1M
3
YUM icon
Yum! Brands
YUM
+$51M
4
RPRX icon
Royalty Pharma
RPRX
+$39.8M
5
ETNB
89bio
ETNB
+$28.8M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$102M
2
TPR icon
Tapestry
TPR
+$83M
3
LVS icon
Las Vegas Sands
LVS
+$78.1M
4
UNP icon
Union Pacific
UNP
+$56.7M
5
T icon
AT&T
T
+$54.3M

Sector Composition

Rank Sector Weight
1 Healthcare 47.29%
2 Consumer Discretionary 12.85%
3 Technology 6.69%
4 Communication Services 5.61%
5 Consumer Staples 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
51
Agios Pharmaceuticals
AGIO
$1.93B
$10.4M 0.44%
454,000
-231,772
-34% -$6.16M
PEPG icon
52
PepGen
PEPG
$197M
$10.1M 0.43%
828,087
– –
EYPT icon
53
EyePoint Inc
EYPT
$1.2B
$9.98M 0.42%
3,394,897
+47,000
+1% +$168K
JNJ icon
54
Johnson & Johnson
JNJ
$625B
$8.57M 0.36%
55,290
+26,000
+89% +$4.2M
ARQT icon
55
Arcutis Biotherapeutics
ARQT
$3.18B
$7.47M 0.32%
+679,391
New +$9.83M
SANA icon
56
Sana Biotechnology
SANA
$980M
$6.91M 0.29%
+2,113,800
New +$8.45M
AKLI
57
DELISTED
Akili Inc
AKLI
$6.15M 0.26%
3,841,718
+217,555
+6% +$340K
MREO
58
Mereo BioPharma
MREO
$47.3M
$5.21M 0.22%
7,364,438
– –
BNTX icon
59
BioNTech
BNTX
$23.5B
$5.1M 0.22%
40,970
+10,370
+34% +$1.42M
IFRX icon
60
InflaRx
IFRX
$271M
$4.16M 0.18%
2,146,240
– –
ELAN icon
61
Elanco Animal Health
ELAN
$11.1B
$4.11M 0.17%
436,900
+82,500
+23% +$973K
TMO icon
62
Thermo Fisher Scientific
TMO
$220B
$2.92M 0.12%
5,060
+1,700
+51% +$958K
NTRA icon
63
Natera
NTRA
$46.4B
$2.88M 0.12%
51,900
– –
DHR icon
64
Danaher
DHR
$144B
$2.8M 0.12%
12,551
+4,168
+50% +$948K
INCY icon
65
Incyte
INCY
$24.4B
$2.72M 0.11%
+37,600
New +$2.94M
AZN icon
66
AstraZeneca
AZN
$250B
$2.49M 0.11%
17,945
+10,100
+129% +$1.36M
MOLN
67
Molecular Partners
MOLN
$152M
$2.42M 0.1%
400,000
– –
ABT icon
68
Abbott
ABT
$187B
$2.09M 0.09%
20,620
+10,310
+100% +$1.09M
ILMN icon
69
Illumina
ILMN
$28.4B
$2.03M 0.09%
8,974
+6,085
+211% +$1.25M
GILD icon
70
Gilead Sciences
GILD
$165B
$1.88M 0.08%
+22,700
New +$1.88M
LKFT
71
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$1.82M 0.08%
47,200
– –
IQV icon
72
IQVIA
IQV
$39.3B
$1.43M 0.06%
7,175
+4,216
+142% +$901K
MDT icon
73
Medtronic
MDT
$112B
$1.41M 0.06%
17,460
+8,094
+86% +$660K
RETA
74
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.37M 0.06%
+15,100
New +$886K
CVS icon
75
CVS Health
CVS
$122B
$1.28M 0.05%
17,170
+14,300
+498% +$1.2M
1 2
3
4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Suvretta Capital Management held 115 positions worth $2.37B, down 0.57% from $2.38B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management's Q1 2023 filing shows 26 new, 36 increased, 14 reduced and 20 closed positions. Its largest new stake was Amazon: 559,490 shares worth $57.8M. The largest sale was Otis Worldwide, an estimated $102M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Suvretta Capital Management's largest Q1 2023 buy was Amazon: 559,490 shares worth $57.8M.
  • Suvretta Capital Management added most to Elevance Health in Q1 2023, an estimated $60.1M increase.
  • Suvretta Capital Management's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $56.7M.
  • Suvretta Capital Management fully exited Otis Worldwide in Q1 2023, selling an estimated $102M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.37B portfolio in Q1 2023.
  • Suvretta Capital Management opened 26 new positions and closed 20 in Q1 2023.
  • Suvretta Capital Management's portfolio value fell 0.57% quarter-over-quarter to $2.37B.

Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.